Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK ROOSENS from Kortenberg, company number BE0461662491, closed financial year 2025 with a result of € 44,659 after tax. For that financial year APOTHEEK ROOSENS recorded a gross margin of € 307,272 and equity of € 254,888. Compared with financial year 2024, the result moved from € 63,769 to € 44,659. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.
€ 254,888
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 44,659
▼ 30% vs 2024
Profit after tax over the fiscal year.
€ 202,694
▲ € 189,530 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 44,000 paid out
99 % of the profit went to the shareholders, mostly to R2 FARMA (100 % of the shares). That is where the money ends up.
People and assets in 2025
2.7
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 214,729
▲ 7% vs 2024
€ 79,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 210,000
▼ 43% vs 2024
€ 23,333 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 637,672
▲ 70% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,327
▲ 9% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 277,166 | € 284,688 | € 319,044 | € 307,272 | ▼ 4% |
| Profit after taxes | € 38,435 | € 34,712 | € 63,769 | € 44,659 | ▼ 30% |
| Equity | € 253,748 | € 253,960 | € 254,229 | € 254,888 | |
| Total debts | € 707,482 | € 742,897 | € 864,627 | € 947,315 | ▲ 10% |
| Cash | € 15,848 | € 23,036 | € 13,164 | € 202,694 | ▲ € 189,530 |
| Land & buildings | € 600,067 | € 588,949 | € 573,162 | € 552,662 | ▼ 4% |
| Retained profit | € 191,748 | € 191,960 | € 192,229 | € 192,888 | |
| Dividend | € 38,000 | € 34,500 | € 63,500 | € 44,000 | ▼ 31% |
| Bank debt | € 518,182 | € 513,576 | € 368,970 | € 210,000 | ▼ 43% |
| Balance sheet total | € 961,230 | € 996,857 | € 1,118,856 | € 1,202,203 | ▲ 7% |
| Employees (FTE) | 2.8 | 2.7 | 2.6 | 2.7 | ▲ 0.1 |
Key figures of APOTHEEK ROOSENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK ROOSENS?
What happened at APOTHEEK ROOSENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 44,659 (▼ 30% vs 2024). filed late Source: NBB ↗
- New establishment in Kortenberg. KBO
- Start of the company according to the CBE. KBO
In short
From € 38,435 profit in 2022 to € 44,659 profit in 2025.
Paid € 12,767 in corporate taxes since 2022.
Best year ever: 2024, with € 63,769 profit.
On average € 113,800 of value added per employee in 2025.
A new publication or filing at APOTHEEK ROOSENS? We notify you, reason included.
Follow APOTHEEK ROOSENSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of R2 FARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK ROOSENSBehind APOTHEEK ROOSENS is R2 Farma BV. The shares are held by R2 FARMA (100%).
Directors
According to the 2025 annual accounts
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Leuvensesteenweg 343
3070 Kortenberg
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
OVH Mail
Hosting
OVH, FR
DNS
OVH DNS
Website info
Features
Security
Details
- Company number
- 0461.662.491
- VAT number
- BE 0461.662.491
- Registered office
- Leuvensesteenweg 343, 3070 Kortenberg
- Names & denominations
- APOTHEEK ROOSENS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 October 1997
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- apotheekroosens.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen